All Search Results
-
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Assess the Safety and Efficacy of Tenapanor for the Treatment of IBS-C in Pediatric Patients 12 to 18 Years Old
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Assess the Safety and Efficacy of Tenapanor for the Treatment of Irritable
-
American Thrombosis and Hemostasis Network ATHNdataset Registry
American Thrombosis and Hemostasis Network ATHNdataset Registry
-
Children’s Brain Tumor Network (CBTN) Collection Protocol
Children’s Brain Tumor Network (CBTN) Collection Protocol
-
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
-
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
Phase II Trial of Eflornithine/DFMO as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma
-
Human Neurophysiology in Epilepsy Patients
Human Neurophysiology in Epilepsy Patients
-
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Phase II Trial of Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
-
VALIDATION OF THE SURGIMEASURE TOOL FOR REAL-TIME INTRAOPERATIVE DISTANCE MEASUREMENT USING DE-IDENTIFIED ROBOTIC AND LAPAROSCOPIC VIDEO DATA
VALIDATION OF THE SURGIMEASURE TOOL FOR REAL-TIME INTRAOPERATIVE DISTANCE MEASUREMENT USING DE-IDENTIFIED ROBOTIC AND LAPAROSCOPIC VIDEO DATA
-
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Phase I/II Study of Silmitasertib (CX-4945) in Combination With Chemotherapy in Children and Young Adults With Relapsed Refractory Solid Tumors
-
Beat Childhood Cancer Specimen Banking and Data Registry
Specimen Banking With Clinical and Genomic Data Registry With the Establishment of Tumor Models for Pediatric Cancers
